(Q38168055)

30 August 2017

Mechanisms and assessment of IgG4-related disease: lessons for the rheumatologist (English)

1 reference

30 August 2017

1 reference

retroperitoneal fibrosis

1 reference

2

Hiroki Takahashi

1 reference

30 August 2017

Motohisa Yamamoto

1

1 reference

30 August 2017

Yasuhisa Shinomura

series ordinal

3

1 reference

30 August 2017

language of work or name

English

0 references

publication date

3 December 2013

1 reference

Nature Reviews Rheumatology

30 August 2017

1 reference

30 August 2017

10

1 reference

30 August 2017

3

1 reference

30 August 2017

148-159

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2013.183

30 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Prevalence of IgG4-Related Disease in Japan Based on Nationwide Survey in 2009.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Nationwide epidemiological survey of autoimmune pancreatitis in Japan.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

The probable systemic nature of Mikulicz's disease and its relation to Sjögren's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Elevated IgG4 concentrations in serum of patients with Mikulicz's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Clinical and pathological differences between Mikulicz's disease and Sjögren's syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Chronic inflammatory sclerosis of the pancreas--an autonomous pancreatic disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-1982. A 55-year-old man with eight months of obstructive jaundice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Lymphoplasmacytic sclerosing pancreatitis with cholangitis: a variant of primary sclerosing cholangitis extensively involving pancreas

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

High serum IgG4 concentrations in patients with sclerosing pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Idiopathic chronic pancreatitis with periductal lymphoplasmacytic infiltration: clinicopathologic features of 35 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Recent advances in autoimmune pancreatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

A case of Mikulicz's disease complicated by autoimmune pancreatitis, in which impaired glucose tolerance was improved by glucocorticoid treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

A new clinicopathological entity of IgG4-related autoimmune disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Consensus statement on the pathology of IgG4-related disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Two critical genes (HLA-DRB1 and ABCF1)in the HLA region are associated with the susceptibility to autoimmune pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Polymorphism in the KCNA3 gene is associated with susceptibility to autoimmune pancreatitis in the Japanese population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Identification of a novel antibody associated with autoimmune pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Tetranectin, a trimeric plasminogen-binding C-type lectin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Involvement of activation of Toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Toll-like receptor activation in basophils contributes to the development of IgG4-related disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Analysis of IgG4 class switch-related molecules in IgG4-related disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

31 March 2020

IgG4 breaking the rules

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Immunoglobulin G4: an odd antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Mechanisms of immunotherapy to wasp and bee venom

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

A novel immunoglobulin-immunoglobulin interaction in autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

The immunobiology and clinical characteristics of IgG4 related diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

An amplification of IL-10 and TGF-beta in patients with IgG4-related tubulointerstitial nephritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Utility of FDG PET/CT in IgG4-related systemic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Chronic sclerosing dacryoadenitis: part of the spectrum of IgG4-related Sclerosing disease?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Küttner's tumor).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Sonographic diagnosis for Mikulicz disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Characteristics of pancreatic diabetes in patients with autoimmune pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Autoimmune pancreatitis: CT and MR characteristics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

A case of Mikulicz's disease (IgG4-related plasmacytic disease) complicated by autoimmune hypophysitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Orbital inflammation in IgG4-related sclerosing disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Pathological findings of infraorbital nerve enlargement in IgG4-related ophthalmic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Clinical features of a new disease concept, IgG4-related thyroiditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Pulmonary involvement of autoimmune pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Immunoglobulin G4-related lung disease: clinicoradiological and pathological features.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

31 March 2020

Retroperitoneal fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Clinical features of 10 patients with IgG4-related retroperitoneal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Ruptured abdominal aortic aneurysm related to IgG4 periaortitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

IgG4-associated prostatitis complicating autoimmune pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Subclassification of autoimmune pancreatitis: a histologic classification with clinical significance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Distinctive Pulmonary Histopathology With Increased IgG4-positive Plasma Cells in Patients With Autoimmune Pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Necessity of early intervention for IgG4-related disease--delayed treatment induces fibrosis progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Analysis of serum IgG subclasses in Churg-Strauss syndrome--the meaning of elevated serum levels of IgG4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

IgG4-Related Lymphadenopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Pancreatic cancer with a high serum IgG4 concentration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

The amendment of the Clinical Diagnostic Criteria in Japan (JPS2011) in response to the proposal of the International Consensus of Diagnostic Criteria (ICDC) for autoimmune pancreatitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Proposal for diagnostic criteria for IgG4-related kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

The diagnostic criteria for autoimmune chronic pancreatitis: it is time to make a consensus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Diagnosis of IgG4-related tubulointerstitial nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Beneficial effects of steroid therapy for Mikulicz's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Relapse patterns in IgG4-related disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Risk of cancer in patients with autoimmune pancreatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Risk of malignancies in IgG4-related disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2013.183

Refractory autoimmune pancreatitis: azathioprine or steroid pulse therapy?

31 March 2020

1 reference

12 December 2020

Recurrence of IgG4-related disease following treatment with rituximab

1 reference

12 December 2020

A clinicopathologic study of Mikulicz's disease

1 reference

12 December 2020

A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease

1 reference

12 December 2020

Inhibition of complement activation by IgG4 antibodies

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2013.183

1 reference

Dimensions Publication ID

30 August 2017

0 references

1 reference